URACYL-SPIROOXETAN-NUKLEOSIDE

European patent · EP2861611 · Deleted

Register entry

Publication number
EP2861611
Application number
EP13727080
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 24, 2013
Published
Apr 22, 2015
Granted
Jul 13, 2016
Deleted
Dec 23, 2025
Reason
Annual fee unpaid
IPC classes
C07H 19/11 (2006.01)
A61K 31/7072 (2006.01)
A61P 31/14 (2006.01)
Priority
EP 12169425 25.05.2012
PCT application
PCT/EP2013/060704 24.05.2013
PCT publication
WO2013/174962 28.11.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.12.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.12.2025

  2. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  3. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  4. Jul 13, 2016

    Granted

    Published in Swissreg on 13.07.2016

Parties

Holder

Janssen Sciences Ireland UC

Eastgate Village, Eastgate, Little Island, County Cork, IE

Inventor

HOUPIS, Ioannis Nicolaos

B-2018 Antwerp, BE

JONCKERS, Tim Hugo Maria

B-2220 Heist-op-den-Berg, BE

RABOISSON, Pierre Jean-Marie Bernard

B-1331 Rosieres, BE

TAHRI, Abdellah

B-1070 Anderlecht, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.